Salvianolic acid B ameliorates myocardial fibrosis in diabetic cardiomyopathy by deubiquitinating Smad7

Salvianolic acid B ameliorates myocardial fibrosis in diabetic cardiomyopathy by deubiquitinating Smad7

Abstract Background Salvianolic acid B (Sal B), a water-soluble phenolic compound derived from Salvia miltiorrhiza Bunge, is commonly used in Traditional Chinese Medicine to treat cardiovascular disease. In our previous study, Sal B protected against myocardial fibrosis induced by diabetic cardiomyo...

Full description

Bibliographic Details
Main Authors:	Hong Luo, Lingyun Fu, Xueting Wang, Yini Xu, Ling Tao, Xiangchun Shen
Format:	Article
Language:	English
Published:	BMC 2023-12-01
Series:	Chinese Medicine
Subjects:	Salvianolic acid B Diabetic cardiomyopathy Myocardial fibrosis TGF-β1 signaling pathway Deubiquitinating Smad7
Online Access:	https://doi.org/10.1186/s13020-023-00868-9

Similar Items

Salvianolic acid B improves DEN/CCl4/C2H5OH-induced renal fibrosis by regulating YAP/TAZ and pSmad3C/pSmad3L
by: Lili Li, et al.
Published: (2024-11-01)

Epidermal Growth Factor‐Like Repeats and Discoidin I‐Like Domains 3 Deficiency Attenuates Dilated Cardiomyopathy by Inhibiting Ubiquitin Specific Peptidase 10 Dependent Smad4 Deubiquitination
by: Mengmeng Zhao, et al.
Published: (2024-03-01)

Salvianolic Acid A Improves Rat Kidney Injury by Regulating MAPKs and TGF-β1/Smads Signaling Pathways
by: Hai-Yang Diao, et al.
Published: (2023-04-01)

Activation of Kir2.1 improves myocardial fibrosis by inhibiting Ca <sup>2+</sup> overload and the TGF-β1/Smad signaling pathway
by: Rong Yi, et al.
Published: (2023-05-01)

Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-β1/Smad3 Pathway in Myocardial Infarction Mice
by: Xiang Li, et al.
Published: (2016-09-01)

Natural products targeting ubiquitination to combat kidney fibrosis
by: Lianhua Li, et al.
Published: (2025-01-01)

Amelioration of bleomycin induced pulmonary fibrosis by administration of Salvianolic acid B in mice
by: Gulzar Begum, et al.
Published: (2022-11-01)

Peroxisome proliferator-activated receptors gama ameliorates liver fibrosis in non-alcoholic fatty liver disease by inhibiting TGF-β/Smad signaling activation
by: Zhang Qingwei, et al.
Published: (2024-04-01)

Icariin improves cardiac function and remodeling via the TGF-β1/Smad signaling pathway in rats following myocardial infarction
by: Ji Jia, et al.
Published: (2023-12-01)

Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: Focus on the TGF-β/Smad signaling pathway
by: Chunjun Li, et al.
Published: (2023-02-01)

Salvianolic acids and its potential for cardio-protection against myocardial ischemic reperfusion injury in diabetes
by: Yuxin Jiang, et al.
Published: (2024-01-01)

miR-15a-5p regulates myocardial fibrosis in atrial fibrillation by targeting Smad7
by: Dan He, et al.
Published: (2021-12-01)

miR-96-5p regulates myocardial infarction-induced cardiac fibrosis via Smad7/Smad3 pathway
by: Gu Huanyu, et al.
Published: (2022-12-01)

Salvianolic acid B in fibrosis treatment: a comprehensive review
by: Qingzhi Liang, et al.
Published: (2024-07-01)

The total polyphenolic glycoside extract of Lamiophlomis rotata ameliorates hepatic fibrosis through apoptosis by TGF-β/Smad signaling pathway
by: Guoguo Wan, et al.
Published: (2023-02-01)

Efficacy and safety of salvianolate injection in treating acute myocardial infarction: a meta-analysis and systematic literature review
by: Pengfei Chen, et al.
Published: (2024-12-01)

Pathological roles of ubiquitination and deubiquitination systems in sepsis-induced myocardial dysfunction
by: Zhiping Wang, et al.
Published: (2025-01-01)

Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
by: Qian Huang, et al.
Published: (2022-09-01)

The role of fibromodulin in myocardial fibrosis in a diabetic cardiomyopathy rat model
by: Xiyan Dai, et al.
Published: (2025-03-01)

Dapagliflozin Attenuates Myocardial Fibrosis by Inhibiting the TGF-β1/Smad Signaling Pathway in a Normoglycemic Rabbit Model of Chronic Heart Failure
by: Xuefeng Chen, et al.
Published: (2022-05-01)

Changes in Cardiac Function During the Development of Uremic Cardiomyopathy and the Effect of Salvianolic Acid B Administration in a Rat Model
by: Danfu Ma, et al.
Published: (2022-06-01)

Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
by: Qian Huang, et al.
Published: (2024-12-01)

Salvianolic acid B promotes angiogenesis and inhibits cardiomyocyte apoptosis by regulating autophagy in myocardial ischemia
by: Qi Chen, et al.
Published: (2023-11-01)

Myocardial bridging in obstructive hypertrophic cardiomyopathy: a risk factor for myocardial fibrosis
by: Changpeng Song, et al.
Published: (2024-02-01)

Metformin Ameliorates Chronic Colitis-Related Intestinal Fibrosis via Inhibiting TGF-β1/Smad3 Signaling
by: Ying Wang, et al.
Published: (2022-05-01)

Ellagic Acid Inhibits TGFβ1/Smad-Induced Renal Fibrosis in Diabetic Kidney Injury
by: Ozkan Gorgulu, et al.
Published: (2022-12-01)

Sulforaphane (Sul) reduces renal interstitial fibrosis (RIF) by controlling the inflammation and TGF-β/Smad signaling pathway
by: Ziqing Yu, et al.
Published: (2024-01-01)

HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro
by: Jie Zhao, et al.
Published: (2016-05-01)

SULF1 expression is increased and promotes fibrosis through the TGF-β1/SMAD pathway in idiopathic pulmonary fibrosis
by: Meng Tu, et al.
Published: (2024-10-01)

Investigation of SMAD3 and SMAD4 Genes Expression in CML Patients and K562 Cell Line
by: T Mahdloo, et al.
Published: (2023-04-01)

Differential regulation of TGF-β/Smad signaling in hepatic stallate cells between acute and chronic liver injuries
by: Katsunori eYoshida, et al.
Published: (2012-03-01)

Gastrodin attenuates diabetic cardiomyopathy characterized by myocardial fibrosis by inhibiting the KLK8-PAR1 signaling axis
by: MingShan Zhang, et al.
Published: (2024-11-01)

Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis
by: Peng Lu, et al.
Published: (2022-05-01)

Evaluation of diastolic dysfunction in children with hypertrophic cardiomyopathy and its relationship with development of myocardial fibrosis
by: Salem Elsayed Deraz, et al.
Published: (2023-06-01)

Ganoderma Lucidum Polysaccharide Peptide attenuates post myocardial infarction fibrosis via down-regulating TGF-β1/SMAD and relieving oxidative stress
by: Jia Meng, et al.
Published: (2022-09-01)

Systemic inflammation is associated with myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy
by: Xinli Guo, et al.
Published: (2025-02-01)

Yes-Associated Protein is Involved in Myocardial Fibrosis in Rats with Diabetic Cardiomyopathy
by: Hu M, et al.
Published: (2021-05-01)

Aluminum exposure induces nephrotoxicity via fibrosis and apoptosis through the TGF-β1/Smads pathway in vivo and in vitro
by: Hua Wei, et al.
Published: (2023-01-01)

PARP9 affects myocardial function through TGF-β/Smad axis and pirfenidone
by: Nannan Chen, et al.
Published: (2024-03-01)

Role of Pericytes in Cardiomyopathy-Associated Myocardial Infarction Revealed by Multiple Single-Cell Sequencing Analysis
by: Yanqiao Lu, et al.
Published: (2023-10-01)